Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
Li‐Ping Ge, Xi Jin, Ding Ma, et al.
Cell Research (2024) Vol. 34, Iss. 1, pp. 58-75
Closed Access | Times Cited: 12

Showing 12 citing articles:

The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8
Computed Tomography-Based Intratumor Heterogeneity Predicts Response to Immunotherapy Plus Chemotherapy in Esophageal Squamous Cell Carcinoma
Fangzeng Lin, Lianxin Zhu, Zi‐Ming Ye, et al.
Academic Radiology (2024) Vol. 31, Iss. 12, pp. 4886-4899
Closed Access | Times Cited: 4
Extensive binding of uncharacterized human transcription factors to genomic dark matter
Rozita Razavi, Ali Fathi, Isaac Yellan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Structural Engineering of Sonosensitive Nanohybrids by Active Vanadium Species toward Collapse of Multi‐Antioxidant Defenses and Boosted Therapy of Triple‐Negative Breast Cancer
Tingting Zhang, Jing Zhu, Yunyun Wu, et al.
Small Structures (2025)
Open Access
Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Hao Li, Ying Chang, Tiefeng Jin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
LINE-1 transposable element renaissance in aging and age-related diseases
Xiang Li, Huaxin Yu, Dong Li, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102440-102440
Closed Access | Times Cited: 3
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11466-11466
Open Access | Times Cited: 3
Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
Tian-Qi Gu, Yu-Ling Xiao, Zhi-Ming Shao
Precision medicine and engineering. (2024) Vol. 1, Iss. 1, pp. 100006-100006
Open Access | Times Cited: 1
Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy
Junsha An, Yajie Lu, Yuxi Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Targeting transposable elements in cancer: developments and opportunities
Zi-Yu Wang, Li‐Ping Ge, Yang Ouyang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189143-189143
Closed Access
CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profiling
Xinyi Huang, Baoqing Tian, Ziyuan Ren, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Single-cell technology for drug discovery and development
A Zhang, Jiawei Zou, Yue Xi, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
Page 1

Scroll to top